Tag Archives: DEPO

Analysts’ Perspective: DepoMed (DEPO), Viper Energy Partners (VNOM), Earthstone Energy (ESTE)

DepoMed Inc. (NASDAQ:DEPO) shares were upgraded by analysts at Mizuho from Neutral to Buy rating with a price target of $9.

Depomed, Inc. is a pharmaceutical company, which manufactures and distributes pharmaceutical products to treat pain and other central nervous system conditions.


Brokerage Firm UBS upgraded Viper Energy Partners L.P. (NASDAQ:VNOM) shares from Neutral to Buy rating while increasing their price target from $19 to $27.

Viper Energy Partners LP engages in the provision of oil exploitation.


Investment Analysts at Seaport Global Securities Earthstone Energy Inc. (NYSE:ESTE) shares from Neutral to Buy rating with a price target of $11.

Earthstone Energy, Inc. engages in the acquisition, exploration, development, and production of crude oil and natural gas properties.


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. CRWE.Info is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://www.crwe.info/disclaimer/